MATINAS BIOPHARMA HOLDINGS, INC. Increase (Decrease) in Other Operating Assets
MATINAS BIOPHARMA HOLDINGS, INC. (MTNB) reported Increase (Decrease) in Other Operating Assets of -$4.84 thousand for the 12-month period ending 2017-12-31, per its 10-K filed 2019-04-01.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOtherOperatingAssets · last filed 2019-04-01
- MATINAS BIOPHARMA HOLDINGS, INC. increase (decrease) in other operating assets for the quarter ending 2017-12-31 was $236.00, a 99.96% decline year-over-year.
- MATINAS BIOPHARMA HOLDINGS, INC. increase (decrease) in other operating assets for the quarter ending 2017-09-30 was -$5.00, a 119.23% decline year-over-year.
- MATINAS BIOPHARMA HOLDINGS, INC. increase (decrease) in other operating assets for the quarter ending 2017-06-30 was -$4.38K.
- MATINAS BIOPHARMA HOLDINGS, INC. increase (decrease) in other operating assets for the quarter ending 2017-03-31 was -$700.00, a 1420.75% decline year-over-year.
- MATINAS BIOPHARMA HOLDINGS, INC. increase (decrease) in other operating assets for fiscal 2017 was -$4.84K, a 101.01% decline from fiscal 2016.
- MATINAS BIOPHARMA HOLDINGS, INC. increase (decrease) in other operating assets for fiscal 2016 was $480.76K.
- MATINAS BIOPHARMA HOLDINGS, INC. increase (decrease) in other operating assets for fiscal 2015 was -$100.62K, a 18768.09% decline from fiscal 2014.
- MATINAS BIOPHARMA HOLDINGS, INC. increase (decrease) in other operating assets for fiscal 2014 was $539.00, a 99.83% decline from fiscal 2013.
| Period end | Increase (Decrease) in Other Operating Assets 3 month | Increase (Decrease) in Other Operating Assets 3 month as first filed | Increase (Decrease) in Other Operating Assets 6 month | Increase (Decrease) in Other Operating Assets 9 month | Increase (Decrease) in Other Operating Assets 12 month | Increase (Decrease) in Other Operating Assets 12 month as first filed | Increase (Decrease) in Other Operating Assets 32 month |
|---|---|---|---|---|---|---|---|
| 2017-12-31 | $236.00 derived: 10-K 12 month − 10-Q 9 month · filed 2019-04-01 | $231.00 derived: sum of 2 quarters · filed 2019-04-01 | -$4.14K derived: sum of 3 quarters · filed 2019-04-01 | -$4.84K 10-K · filed 2019-04-01 | -$5.02K 10-K · filed 2018-03-16 | ||
| 2017-09-30 | -$5.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-14 | -$4.38K derived: sum of 2 quarters · filed 2017-11-14 | -$5.08K 10-Q · filed 2017-11-14 | $580.95K derived: sum of 4 quarters · filed 2018-05-09 | |||
| 2017-06-30 | -$4.38K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-08 | -$5.08K 10-Q · filed 2017-08-08 | $580.95K derived: sum of 3 quarters · filed 2018-05-09 | $580.98K derived: sum of 4 quarters · filed 2018-05-09 | |||
| 2017-03-31 | -$700.00 10-Q · filed 2018-05-09 | -$673.00 10-Q · filed 2017-05-15 | $585.33K derived: sum of 2 quarters · filed 2018-05-09 | $585.35K derived: sum of 3 quarters · filed 2018-05-09 | $480.01K derived: sum of 4 quarters · filed 2018-05-09 | ||
| 2016-12-31 | $586.03K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-16 | $586.05K derived: sum of 2 quarters · filed 2018-03-16 | $480.71K derived: sum of 3 quarters · filed 2018-03-16 | $480.76K 10-K · filed 2018-03-16 | |||
| 2016-09-30 | $26.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-14 | -$105.32K derived: sum of 2 quarters · filed 2017-11-14 | -$105.27K 10-Q · filed 2017-11-14 | -$206.13K derived: sum of 4 quarters · filed 2018-03-16 | |||
| 2016-06-30 | -$105.35K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-08 | -$105.30K 10-Q · filed 2017-08-08 | -$206.15K derived: sum of 3 quarters · filed 2018-03-16 | -$206.07K derived: sum of 4 quarters · filed 2018-03-16 | |||
| 2016-03-31 | $53.00 10-Q · filed 2017-05-15 | -$100.81K derived: sum of 2 quarters · filed 2018-03-16 | -$100.73K derived: sum of 3 quarters · filed 2018-03-16 | -$100.65K derived: sum of 4 quarters · filed 2018-03-16 | |||
| 2015-12-31 | -$100.86K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-16 | -$100.78K derived: sum of 2 quarters · filed 2018-03-16 | -$100.70K derived: sum of 3 quarters · filed 2018-03-16 | -$100.62K 10-K · filed 2018-03-16 | |||
| 2015-09-30 | $80.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-14 | $160.00 derived: sum of 2 quarters · filed 2016-11-14 | $238.00 10-Q · filed 2016-11-14 | -$3.81K derived: sum of 4 quarters · filed 2016-11-14 | |||
| 2015-06-30 | $80.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-15 | $158.00 10-Q · filed 2016-08-15 | -$3.89K derived: sum of 3 quarters · filed 2016-08-15 | -$3.77K derived: sum of 4 quarters · filed 2016-08-15 | |||
| 2015-03-31 | $78.00 10-Q · filed 2016-05-13 | -$3.97K derived: sum of 2 quarters · filed 2016-05-13 | -$3.85K derived: sum of 3 quarters · filed 2016-05-13 | -$40.50K derived: sum of 4 quarters · filed 2016-05-13 | |||
| 2014-12-31 | -$4.05K derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-30 | -$3.93K derived: sum of 2 quarters · filed 2016-03-30 | -$40.58K derived: sum of 3 quarters · filed 2016-03-30 | $539.00 10-K · filed 2016-03-30 | |||
| 2014-09-30 | $120.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-10 | -$36.53K derived: sum of 2 quarters · filed 2015-11-10 | $4.59K 10-Q · filed 2015-11-10 | ||||
| 2014-06-30 | -$36.65K derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-13 | $4.47K 10-Q · filed 2015-08-13 | |||||
| 2014-03-31 | $41.12K 10-Q · filed 2015-05-15 | $356.89K 10-Q · filed 2014-06-06 | |||||
| 2013-12-31 | $315.78K 10-K · filed 2015-03-31 | ||||||
| 2013-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-08 | $0.00 10-Q · filed 2014-08-08 | |||||
| 2013-03-31 | $0.00 10-Q · filed 2014-06-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| Nexentis Technologies Inc. (NXTS) | $0.002B |